Skip to main content

Peer Review reports

From: Immunological and short-term brain volume changes in relapsing forms of multiple sclerosis treated with interferon beta-1a subcutaneously three times weekly: an open-label two-arm trial

Original Submission
12 May 2015 Submitted Original manuscript
Author responded Author comments
Reviewed Reviewer Report
Reviewed Reviewer Report
Resubmission - Version 2
Submitted Manuscript version 2
Reviewed Reviewer Report
Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
31 Oct 2015 Editorially accepted
11 Nov 2015 Article published 10.1186/s12883-015-0488-9

You can find further information about peer review here.

Back to article page